Silver Book Fact

Annual Direct and Indirect Costs of Diabetic Retinopathy

Fact image

Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs. Diabetic Medicine. 2010; 29: 855-62. https://jdrf.org.uk/wp-content/uploads/2015/10/Hex-and-Bartlett.pdf

Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L. Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden. Diabetologia. 2010; 53(10): 2147-54. http://link.springer.com/article/10.1007%2Fs00125-010-1836-3

Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The Economic Burden of Diabetic Retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol. 2008; 246(1): 151-9. http://link.springer.com/article/10.1007%2Fs00417-007-0573-x

Gonzalez J, Walker J, Einarson T. Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia. 2009; 26(1): 55-63. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009000700009

Barcelo A, Aedo C, Rajpathak S, Robles S. The Cost of Diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 2003; 81: 19-27. http://www.who.int/bulletin/Barcelo0103.pdf

Reference

Title
Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs
Publication
Diabetic Medicine
Publication Date
2010
Authors
Hex N, Bartlett C, Wright D, Taylor M, Varley D
Pages
855-62
URL
Read Full Resource
Title
Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden
Publication
Diabetologia
Publication Date
2010
Authors
Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L
Volume & Issue
Volume 53, Issue 10
Pages
2147-54
URL
Read Full Resource
Title
The Economic Burden of Diabetic Retinopathy in Germany in 2002
Publication
Graefes Arch Clin Exp Ophthalmol
Publication Date
2008
Authors
Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J
Volume & Issue
Volume 246, Issue 1
Pages
151-9
URL
Read Full Resource
Title
Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia
Publication Date
2009
Authors
Gonzalez J, Walker J, Einarson T
Volume & Issue
Volume 26, Issue 1
Pages
55-63
URL
Read Full Resource
Title
The Cost of Diabetes in Latin America and the Caribbean
Publication
Bulletin of the World Health Organization
Publication Date
2003
Authors
Barcelo A, Aedo C, Rajpathak S, Robles S
Pages
19-27
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • About 25 percent of those with prediabetes go on to develop diabetes within three to five years.  
  • Health care spending attributable to diabetes is expected to nearly triple by 2034, to $336 billion.  
  • From 2009 to 2034, for the Medicare-eligible population, the diabetes population is expected to rise from 8.2 million in 2009 to 14.6 million in 2034.  
  • Diabetes is the leading cause of kidney failure, adult-onset blindness, and nontraumatic lower limb amputations.  
  • About 1.9 million people aged 20 years or older were newly diagnosed with diabetes in 2010 in the United States.